...
首页> 外文期刊>Graefe's archive for clinical and experimental ophthalmology: Albrecht von Graefes Archiv fur klinische und experimentelle Opthalmologie >Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy
【24h】

Navigated laser photocoagulation in patients with non-resolving and chronic central serous chorioretinopathy

机译:患有非分离和慢性中央浆液性胆小血管病变患者的导航激光光凝

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Purpose To evaluate the efficacy of navigated focal laser photocoagulation in patients with chronic central serous chorioretinopathy (CSCR) and active leakage on fluorescein angiography (FA). Methods Thirty-two eyes of 32 patients (age 48?±?11, m/f?=?24/8) with persistent or recurrent CSCR (>?3?months) who received navigated laser photocoagulation (Navilas?) of leaking point(s) between June 2013 and 2016 were included in this retrospective case series. Outcome parameters after 4?weeks and 3?months were the number of patients presenting with complete resolution of subretinal fluid, the volume of subretinal fluid measured on SD-OCT (Spectralis Heidelberg Engineering?), and best corrected visual acuity (BCVA/ (Snellen equivalent). Results Complete resolution of subretinal fluid was achieved in 17 eyes (50%) after 4?weeks and in 24 eyes (75%) after 3?months with an average number of 1.3 laser procedures (range 1–3). Five eyes displayed a nearly complete resolution with a reduction of over 80% of the subretinal fluid compared to baseline. Three eyes showed no reduction in subretinal fluid. BCVA improved from median 0.58 (range 0.16–1.25) to 0.66 (0.16–1.0) ( p ?=?0.001). The seven patients who had been treated within the central 1?mm of the ETDRS-OCT Grid but outside the avascular foveal zone showed an improvement of BCVA from median 0.6 (range 0.2–1.0) to 0.8 (0.2–1.0). No patient experienced a treatment-induced visual loss. Conclusions Laser treatment with Navilas? using eye tracking and FA-based planning is a safe and effective alternative therapy in patients with chronic CSCR.
机译:目的,评价慢性中央浆液性肺病变(CSCR)患者导航局灶性激光光凝患者的疗效,对荧光素血管造影(FA)的活性渗漏。方法32例患者的32只眼睛(48岁? (s)2013年6月至2016年间包括在此回顾性案例系列中。结果参数在4周和3个月后参数是呈现细分分辨率的患者的数量,在SD-OCT(Spectralis Heidelberg Engineering)上测量的分子液的体积,以及最佳矫正视力(BCVA /(Snellen当量)。结果在4〜30次和24只眼睛(75%)后17只眼(50%)在17只眼内(50%)完成分辨率的分辨率,平均1.3激光程序(范围1-3)。五与基线相比,眼睛展示了几乎完整的分辨率,减少了超过80%的子液体。三眼没有减少沉积液。BCVA从中值改善0.58(0.16-1.25)至0.66(0.16-1.0)(p ?=?0.001)。七名患者在中央1?MM的ETDRS-OCT网格中进行处理,但在缺血性污水区外,从中值0.6(范围0.2-1.0)至0.8(0.2- 1.0)。没有患者经历过治疗引起的视觉损失。结论纳米利空激光治疗?使用眼追踪和基于FA的规划是慢性CSCR患者的安全有效的替代疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号